Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Suzuken Co ( (JP:9987) ) has shared an update.
Suzuken has completed a share repurchase program authorized in May 2025, underscoring continued efforts to optimize its capital structure and enhance shareholder returns. In the latest tranche conducted from March 2 to March 6, 2026, the company bought back 104,100 shares on the Tokyo Stock Exchange for about 671.8 million yen.
Under the full program period running from May 15, 2025 to March 19, 2026, Suzuken cumulatively repurchased 4,458,800 shares for roughly 26.0 billion yen, just below the approved monetary ceiling and share limit. The completion of this sizeable buyback signals active capital allocation and may support earnings per share and shareholder value, while modestly reducing the company’s free float.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen6959.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. is a Japan-based company listed on the Prime Market of the Tokyo and Nagoya Stock Exchanges and the Sapporo Securities Exchange. It operates in the healthcare and pharmaceutical distribution sector, focusing on supplying medicines and related services to medical institutions and pharmacies across Japan.
YTD Price Performance: 3.57%
Average Trading Volume: 175,872
Technical Sentiment Signal: Buy
Current Market Cap: Yen360.5B
For an in-depth examination of 9987 stock, go to TipRanks’ Overview page.